|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ABII 8-K filed Nov 8, 2007. General We will be authorized to issue 106,000,000 shares: 100,000,000 shares will be designated as common stock and 6,000,000 shares will be designated preferred stock. The following description of our capital stock is subject to, and qualified in its entirety by, the provisions of our certificate of incorporation and bylaws, which are included as exhibits to the registration statement of which this information statement is a part, and by the provisions of applicable law. Based on the number of shares of Abraxis BioScience common stock outstanding as of June 30, 2007 and the distribution ratio, we expect that approximately 40 million shares of our common stock will be distributed to Abraxis BioScience stockholders in the distribution. All the shares of our common stock to be distributed to Abraxis BioScience stockholders in the distribution will be fully paid and non-assessable and will constitute all the shares of our capital stock that will be outstanding immediately after the distribution. |
| |||||||
